Episode 20: Asaf Shiloni Of Kadimastem (Podcast)

Published date03 November 2022
Subject MatterIntellectual Property, Patent
Law FirmJMB Davis Ben-David Ltd.
AuthorMr Avraham Hermon

Asaf Shiloni, a veteran biotech founder and manager is the CEO of Kadimastem a clinical stage biotech company, that is creating cell therapy that enables the production of off-the-shelf cell-based products for the treatment of unmet medical needs such as ALS and a cure for Diabetes.

Avraham sat down with Asaf in the offices of Kadimastem to discuss how Kadimastem is creating and testing their innovative therapies, why...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT